Ventas Announces Pricing of Senior Notes Offering
Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that it has priced a public offering of $450 million
aggregate principal amount of 3.25% Senior Notes due 2026 (the “Notes”) at 99.811% of the principal amount. The Notes are being
issued by the Company’s operating partnership, Ventas Realty, Limited Partnership, and will be guaranteed, on a senior unsecured
basis, by the Company. The sale of the Notes is expected to close on September 21, 2016, subject to customary closing
conditions.
The Company expects to use the net proceeds from the offering for working capital and other general corporate purposes, which
may include the repayment of indebtedness.
Citigroup Global Markets Inc., Barclays Capital Inc., Credit Agricole Securities (USA) Inc. and Credit Suisse
Securities (USA) LLC acted as joint book-running managers for the offering of the Notes.
The Notes are being offered pursuant to the Company’s existing shelf registration statement, which became automatically
effective upon filing with the Securities and Exchange Commission. A prospectus supplement and accompanying prospectus describing
the terms of the offering will be filed with the Securities and Exchange Commission. When available, copies of the prospectus
supplement and the accompanying prospectus may be obtained from: Citigroup Global Markets Inc., c/o Broadridge Financial Solutions,
1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 1-800-831-9146 or by email at prospectus@citi.com; Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue,
Edgewood, NY 11717, barclaysprospectus@broadridge.com, (888)
603-5847; Credit Agricole Securities (USA) Inc., Attention: Debt Syndicate, 1301 Avenue of the Americas, New York, New York 10019,
telephone: 212-261-3678; or Credit Suisse Securities (USA) LLC, Attention: Prospectus Department, One Madison Avenue, New York, NY
10010, or by telephone at (800) 221-1037, or by email at newyork.prospectus@credit-suisse.com.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sales of
these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of such jurisdiction.
Ventas, Inc., an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of approximately 1,300
assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, life
science buildings, skilled nursing facilities, specialty hospitals and general acute care hospitals. Through its Lillibridge
subsidiary, Ventas provides management, leasing, marketing, facility development and advisory services to highly rated hospitals
and health systems throughout the United States.
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding the Company’s or its
tenants’, operators’, borrowers’ or managers’ expected future financial condition, results of operations, cash flows, funds from
operations, dividends and dividend plans, financing opportunities and plans, capital markets transactions, business strategy,
budgets, projected costs, operating metrics, capital expenditures, competitive positions, acquisitions, investment opportunities,
dispositions, merger or acquisition integration, growth opportunities, expected lease income, continued qualification as a real
estate investment trust (“REIT”), plans and objectives of management for future operations and statements that include words such
as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will” and other similar
expressions are forward-looking statements. These forward-looking statements are inherently uncertain, and actual results
may differ from the Company’s expectations. The Company does not undertake a duty to update these forward-looking
statements, which speak only as of the date on which they are made.
The Company’s actual future results and trends may differ materially from expectations depending on a variety of factors
discussed in the Company’s filings with the Securities and Exchange Commission. These factors include without limitation:
(a) the ability and willingness of the Company’s tenants, operators, borrowers, managers and other third parties to satisfy their
obligations under their respective contractual arrangements with the Company, including, in some cases, their obligations to
indemnify, defend and hold harmless the Company from and against various claims, litigation and liabilities; (b) the ability of the
Company’s tenants, operators, borrowers and managers to maintain the financial strength and liquidity necessary to satisfy their
respective obligations and liabilities to third parties, including without limitation obligations under their existing credit
facilities and other indebtedness; (c) the Company’s success in implementing its business strategy and the Company’s ability to
identify, underwrite, finance, consummate and integrate diversifying acquisitions and investments; (d) macroeconomic conditions
such as a disruption of or lack of access to the capital markets, changes in the debt rating on U.S. government securities, default
or delay in payment by the United States of its obligations, and changes in the federal or state budgets resulting in the reduction
or nonpayment of Medicare or Medicaid reimbursement rates; (e) the nature and extent of future competition, including new
construction in the markets in which the Company’s seniors housing communities and medical office buildings (“MOBs”) are
located; (f) the extent of future or pending healthcare reform and regulation, including cost containment measures and changes in
reimbursement policies, procedures and rates; (g) increases in the Company’s borrowing costs as a result of changes in interest
rates and other factors; (h) the ability of the Company’s tenants, operators and managers, as applicable, to comply with laws,
rules and regulations in the operation of the Company’s properties, to deliver high-quality services, to attract and retain
qualified personnel and to attract residents and patients; (i) changes in general economic conditions or economic conditions in the
markets in which the Company may, from time to time, compete, and the effect of those changes on the Company’s revenues, earnings
and funding sources; (j) the Company’s ability to pay down, refinance, restructure or extend its indebtedness as it becomes due;
(k) the Company’s ability and willingness to maintain its qualification as a REIT in light of economic, market, legal, tax and
other considerations; (l) final determination of the Company’s taxable net income for the year ended December 31, 2015 and for the
year ending December 31, 2016; (m) the ability and willingness of the Company’s tenants to renew their leases with the Company upon
expiration of the leases, the Company’s ability to reposition its properties on the same or better terms in the event of nonrenewal
or in the event the Company exercises its right to replace an existing tenant, and obligations, including indemnification
obligations, the Company may incur in connection with the replacement of an existing tenant; (n) risks associated with the
Company’s senior living operating portfolio, such as factors that can cause volatility in the Company’s operating income and
earnings generated by those properties, including without limitation national and regional economic conditions, development of new,
competing properties, costs of food, materials, energy, labor and services, employee benefit costs, insurance costs and
professional and general liability claims, and the timely delivery of accurate property-level financial results for those
properties; (o) changes in exchange rates for any foreign currency in which the Company may, from time to time, conduct business;
(p) year-over-year changes in the Consumer Price Index or the UK Retail Price Index and the effect of those changes on the rent
escalators contained in the Company’s leases and on the Company’s earnings; (q) the Company’s ability and the ability of its
tenants, operators, borrowers and managers to obtain and maintain adequate property, liability and other insurance from reputable,
financially stable providers; (r) the impact of increased operating costs and uninsured professional liability claims on the
Company’s liquidity, financial condition and results of operations or that of the Company’s tenants, operators, borrowers and
managers, and the ability of the Company and the Company’s tenants, operators, borrowers and managers to accurately estimate the
magnitude of those claims; (s) risks associated with the Company’s MOB portfolio and operations, including the Company’s ability to
successfully design, develop and manage MOBs and to retain key personnel; (t) the ability of the hospitals on or near whose
campuses the Company’s MOBs are located and their affiliated health systems to remain competitive and financially viable and to
attract physicians and physician groups; (u) risks associated with the Company’s investments in joint ventures and unconsolidated
entities, including its lack of sole decision-making authority and its reliance on its joint venture partners’ financial condition;
(v) the impact of market or issuer events on the liquidity or value of the Company’s investments in marketable securities; (w)
consolidation in the seniors housing and healthcare industries resulting in a change of control of, or a competitor’s investment
in, one or more of the Company’s tenants, operators, borrowers or managers or significant changes in the senior management of the
Company’s tenants, operators, borrowers or managers; (x) the impact of litigation or any financial, accounting, legal or regulatory
issues that may affect the Company or its tenants, operators, borrowers or managers; and (y) changes in accounting principles, or
their application or interpretation, and the Company’s ability to make estimates and the assumptions underlying the estimates,
which could have an effect on the Company’s earnings.
Click here to subscribe to Mobile Alerts for Ventas, Inc.
Ventas, Inc.
Ryan Shannon
(877) 4-VENTAS
View source version on businesswire.com: http://www.businesswire.com/news/home/20160914006357/en/